Cargando…
The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients
The risks associated with in vivo and ex vivo use of Campath-1H and -1G in a cohort of 206 stem cell transplant recipients for cytomegalovirus (HCMV) DNAemia have been quantified. DNAemia showed a biphasic incidence pattern with an inflexion at day 60. The first phase had a linear risk rate for HCMV...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829098/ https://www.ncbi.nlm.nih.gov/pubmed/19966846 http://dx.doi.org/10.1038/bmt.2009.329 |